New International Signal Detection Initiative To ‘Influence Industry Practice'
Executive Summary
Drug companies, regulators and academia have joined together under a three-year international project to explore what new methodologies should be developed to make the most of the opportunities provided by big data and artificial intelligence in detecting adverse effects of authorized medicines.